论文部分内容阅读
为探讨早期用药品治疗肾综合征出血热(HFRS)患者对病程的影响,对俄罗斯哈巴罗夫斯克医学院传染病医院曾用药品治疗的173例HFRS患者的病历进行了分析。其中男性占80.3％,年龄25～40岁。患者在病初2～3天未能确诊为HFRS,初步拟诊为急性呼吸道疾病(ARD,128例)、流感(10例)、咽峡炎(3例)、肺炎(2例)、腺病毒感染和肠道病毒感染(各1例),以及肾盂肾炎(1例)。25例患者自行用药,全部患者均用解热剂,其中有阿斯匹林(70.3％)、氨基比林
To investigate the effect of early treatment of HFRS patients on the course of the disease, the medical records of 173 patients with HFRS treated with drugs in the Infectious Diseases Hospital of Khabarovsk Medical College in Russia were analyzed. Of which 80.3% of men, aged 25 to 40 years old. Patients were not diagnosed with HFRS 2 to 3 days early, initially diagnosed as acute respiratory disease (ARD 128), flu (10), angina (3), pneumonia (2), adenovirus Infections and enterovirus infections (1 case each), and pyelonephritis (1 case). 25 patients self medication, all patients with antipyretics, including aspirin (70.3%), aminopyrine